Pharm Tech Minutes 2013.10.10: Difference between revisions
Jump to navigation
Jump to search
Created page with " Pharmacy Technical Committee Category: Minutes" |
|||
| (14 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
== Participants == | |||
* Jürgen Brandstätter (CodeWerk) | |||
* Michael Tan (Nictiz) | |||
* Simon Letellier (EAHP) | |||
* Stephen Chu (NEHTA) | |||
* Jose Costa Teixeira (Agfa) | |||
* Marco Demarmels (Lake Griffin) | |||
* Vincent van Pelt (Nictiz) | |||
* Jacqueline Surugue (EAHP) | |||
== Review of the PML profile proposal and CP to CMPD alongside PML == | |||
* Current version of PML profile | |||
:* Content structure of Medication List | |||
::* PML profile: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-03.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-03.doc] | |||
* Current version of CP | |||
:* Workflow for Medication List | |||
::* CP to CMPD alongside to PML profile: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v2.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v2.doc] | |||
* Discussion | |||
:* Both items have been discussed | |||
:* Michael Tan: Discussion of slide deck about Netherlands requirements | |||
::* [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/Requirements%20in%20NL.pptx ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/Requirements%20in%20NL.pptx] | |||
::* Netherlands require seperate collections of Prescription- and Dispense items | |||
::* CP has been extended to meet this requirements (last page) | |||
:* CP has been changed (added query parameters on last page) | |||
::* New version: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v3.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v3.doc] | |||
:* PML has been changed minor (typo) | |||
::* New version: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-10.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-10.doc] | |||
* Decisions | |||
:* Both PML profile and CP-PHARM-056 belong together and shall be treated as bundle | |||
:* PML profile proposal is approved and will be prepared for Public Comment | |||
:* CP is sent to status "Assigned to Jürgen Brandstätter" and will be further discussed | |||
== New incoming CP and request for approval for ballot == | |||
* CP-PHARM-057: Use of nullFlavor if no code/brand name of medicine is available | |||
:* Approved and moved to status "Assigned to Jürgen Brandstätter" | |||
* CP-PHARM-058: Relax usage of UCUM from SHALL to SHOULD | |||
:* New version v2 because of minor change (typo) | |||
:* Approved and moved to status "Assigned to Jürgen Brandstätter" | |||
* Both CPs are now located in folder "Assigned": | |||
:* [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2014/CPs/Assigned ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2014/CPs/Assigned] | |||
== Review of CPs and request for approval for ballot == | |||
* CP-PHARM-045: Add new implementation scenario “Usage of XDW versus database backend” | |||
:* No change to last time | |||
* CP-PHARM-046: PHARM-1: New Query “FindPrescriptions” | |||
:* No change to last time | |||
* CP-PHARM-047: PHARM-1: New Query “FindDispenses” | |||
:* No change to last time | |||
* CP-PHARM-048: Introduce “repeatNumber” for number of allowed dispenses (Number of repeats) | |||
:* Minor change to last time | |||
* CP-PHARM-049: Relieve optionality at active ingredients | |||
:* Minor change to last time | |||
* CP-PHARM-050: Rule for “non-dispense” | |||
:* No change to last time | |||
* CP-PHARM-051: Relieve the constraint that the whole Presciption item has to be embedded | |||
:* Minor change to last time | |||
* CP-PHARM-052: Relieve the constraint that the whole Presciption item has to be embedded | |||
:* Minor change to last time | |||
* CP-PHARM-053: Relieve the constraint that the whole Pharmaceutical Advice item has to be embedded | |||
:* No change to last time | |||
* CP-PHARM-054: PADV can also reference to Dispense Items (not only Prescription Items) | |||
:* Major change to last time | |||
:* CP has been reviewed and new version released (v4) | |||
* CP-PHARM-055: CMPD Maintenance | |||
:* Major change to last time | |||
* All CPs are now located at FTP: | |||
:* [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2014/CPs/Assigned ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2014/CPs/Assigned] | |||
* Decision | |||
:* All given CPs stay in status "Assigned" | |||
:* Request for approval to ballot postponed to F2F meeting in Paris Oct 30/31, 2013 | |||
[[Pharmacy Technical Committee]] | [[Pharmacy Technical Committee]] | ||
[[Category: Minutes]] | [[Category: Minutes]] | ||
Latest revision as of 09:24, 10 October 2013
Participants
- Jürgen Brandstätter (CodeWerk)
- Michael Tan (Nictiz)
- Simon Letellier (EAHP)
- Stephen Chu (NEHTA)
- Jose Costa Teixeira (Agfa)
- Marco Demarmels (Lake Griffin)
- Vincent van Pelt (Nictiz)
- Jacqueline Surugue (EAHP)
Review of the PML profile proposal and CP to CMPD alongside PML
- Current version of PML profile
- Content structure of Medication List
- Current version of CP
- Workflow for Medication List
- CP to CMPD alongside to PML profile: ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v2.doc
- Discussion
- Both items have been discussed
- Michael Tan: Discussion of slide deck about Netherlands requirements
- ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/Requirements%20in%20NL.pptx
- Netherlands require seperate collections of Prescription- and Dispense items
- CP has been extended to meet this requirements (last page)
- CP has been changed (added query parameters on last page)
- PML has been changed minor (typo)
- Decisions
- Both PML profile and CP-PHARM-056 belong together and shall be treated as bundle
- PML profile proposal is approved and will be prepared for Public Comment
- CP is sent to status "Assigned to Jürgen Brandstätter" and will be further discussed
New incoming CP and request for approval for ballot
- CP-PHARM-057: Use of nullFlavor if no code/brand name of medicine is available
- Approved and moved to status "Assigned to Jürgen Brandstätter"
- CP-PHARM-058: Relax usage of UCUM from SHALL to SHOULD
- New version v2 because of minor change (typo)
- Approved and moved to status "Assigned to Jürgen Brandstätter"
- Both CPs are now located in folder "Assigned":
Review of CPs and request for approval for ballot
- CP-PHARM-045: Add new implementation scenario “Usage of XDW versus database backend”
- No change to last time
- CP-PHARM-046: PHARM-1: New Query “FindPrescriptions”
- No change to last time
- CP-PHARM-047: PHARM-1: New Query “FindDispenses”
- No change to last time
- CP-PHARM-048: Introduce “repeatNumber” for number of allowed dispenses (Number of repeats)
- Minor change to last time
- CP-PHARM-049: Relieve optionality at active ingredients
- Minor change to last time
- CP-PHARM-050: Rule for “non-dispense”
- No change to last time
- CP-PHARM-051: Relieve the constraint that the whole Presciption item has to be embedded
- Minor change to last time
- CP-PHARM-052: Relieve the constraint that the whole Presciption item has to be embedded
- Minor change to last time
- CP-PHARM-053: Relieve the constraint that the whole Pharmaceutical Advice item has to be embedded
- No change to last time
- CP-PHARM-054: PADV can also reference to Dispense Items (not only Prescription Items)
- Major change to last time
- CP has been reviewed and new version released (v4)
- CP-PHARM-055: CMPD Maintenance
- Major change to last time
- All CPs are now located at FTP:
- Decision
- All given CPs stay in status "Assigned"
- Request for approval to ballot postponed to F2F meeting in Paris Oct 30/31, 2013